These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23169283)

  • 1. Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up.
    Jensen KE; Schmiedel S; Norrild B; Frederiksen K; Iftner T; Kjaer SK
    Br J Cancer; 2013 Jan; 108(1):234-9. PubMed ID: 23169283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study.
    Jensen KE; Thomsen LT; Schmiedel S; Frederiksen K; Norrild B; van den Brule A; Iftner T; Kjær SK
    Sex Transm Infect; 2014 Nov; 90(7):550-5. PubMed ID: 24728044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection.
    Jensen KE; Schmiedel S; Frederiksen K; Norrild B; Iftner T; Kjær SK
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1949-55. PubMed ID: 23019238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of smoking on high-grade cervical cancer in women on the basis of human papillomavirus infection studies.
    Fang JH; Yu XM; Zhang SH; Yang Y
    J Cancer Res Ther; 2018; 14(Supplement):S184-S189. PubMed ID: 29578171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort.
    Deacon JM; Evans CD; Yule R; Desai M; Binns W; Taylor C; Peto J
    Br J Cancer; 2000 Dec; 83(11):1565-72. PubMed ID: 11076670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology.
    Castle PE; Walker JL; Schiffman M; Wheeler CM
    Int J Cancer; 2005 Dec; 117(6):1007-12. PubMed ID: 15986443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
    Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
    BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
    Castle PE; Solomon D; Schiffman M; Wheeler CM
    J Natl Cancer Inst; 2005 Jul; 97(14):1066-71. PubMed ID: 16030304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway.
    Vintermyr OK; Iversen O; Thoresen S; Quint W; Molijn A; de Souza S; Rosillon D; Holl K
    Gynecol Oncol; 2014 May; 133(2):159-66. PubMed ID: 24631451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection.
    Kjellberg L; Hallmans G; Ahren AM; Johansson R; Bergman F; Wadell G; Angström T; Dillner J
    Br J Cancer; 2000 Apr; 82(7):1332-8. PubMed ID: 10755410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
    Lehtinen M; Paavonen J; Wheeler CM; Jaisamrarn U; Garland SM; Castellsagué X; Skinner SR; Apter D; Naud P; Salmerón J; Chow SN; Kitchener H; Teixeira JC; Hedrick J; Limson G; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; De Carvalho NS; Germar MJ; Peters K; Mindel A; De Sutter P; Bosch FX; David MP; Descamps D; Struyf F; Dubin G;
    Lancet Oncol; 2012 Jan; 13(1):89-99. PubMed ID: 22075171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.
    McIntyre-Seltman K; Castle PE; Guido R; Schiffman M; Wheeler CM;
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1165-70. PubMed ID: 15894667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
    Schlecht NF; Kulaga S; Robitaille J; Ferreira S; Santos M; Miyamura RA; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
    JAMA; 2001 Dec; 286(24):3106-14. PubMed ID: 11754676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.
    Khan MJ; Partridge EE; Wang SS; Schiffman M
    Cancer; 2005 Jul; 104(1):61-70. PubMed ID: 15889450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.
    Castle PE; Wacholder S; Lorincz AT; Scott DR; Sherman ME; Glass AG; Rush BB; Schussler JE; Schiffman M
    J Natl Cancer Inst; 2002 Sep; 94(18):1406-14. PubMed ID: 12237286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.